Confluent, Amazon MSK, & Apache Kafka
Former Director, Engineering at Confluent
inpractise.com/articles/confluent-amazon-msk-and-apache-kafka
Former Director, Engineering at Confluent
Interview Transcript
This is a snippet of the transcript, sign up to read more.
This gets into the other part of the discussion, which is the monetization of the open source. I don't want to call it a silver bullet in terms of monetizing the open source but do you feel like that's a step change for Confluent in accessing that open-source base?
You have a larger pie that you can sell into of the existing open-source Kafka users, especially the organizations that are like, wow, it's actually pretty hard to run Kafka; many places have teams dedicated to that. Maybe they want to free up those engineers to work on something else. I think that’s pretty compelling, and the ease of getting going with Confluent Cloud is the thing that will drive growth there.
This is a snippet of the transcript, sign up to read more.
Could you compare Confluent Cloud to Kinesis? I'd love to hear your thoughts on it.
Kinesis is more in that SaaS model. You turn it on in the AWS console. You point your client or your API, here's your code at their API, and you fire messages, and it works. The difference, of course, is that if you're doing a lot of volume, Kinesis is egregiously expensive. Kinesis makes a ton of sense at a smaller scale and is definitely compelling. That is the comparison. Kinesis is closer to Confluent Cloud than, I think, MSK is in some sense. Of course, you want to compare MSK because they're both Kafka.
This is a snippet of the transcript, sign up to read more.
Related Content
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.